Skip to content
DataLookout
Menu

NCT04722341

Time-Restricted Eating and Cancer: Clinical Outcomes, Mechanisms, and Moderators

StatusCompleted
PhaseNot applicable
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 13 versions: 11 with changes below, 2 re-verified with no change. See every version on ClinicalTrials.gov ↗

  1. Notable Eligibility criteria expanded, about 22 words Show 7 more changesShow less
    • Trial completed
    • Final enrollment: 98 participants (planned 175)
    • Primary completion date changed from estimate of Jun 30, 2026 to Jul 31, 2026
    • Study completion date changed from estimate of Dec 31, 2026 to Aug 31, 2026
    • Secondary endpoints: details revised at 4 of 4 entries
    • Site details revised at 2 of 2 sites
    • Publications: details revised at 1 of 1 entry
  2. Notable Eligibility criteria expanded, about 52 wordsv12 Show 4 more changesShow less
    • Primary endpoints revised (2)
    • Study sites: 1 to 2
    • Secondary endpoints: 6 to 4
    • Collaborators: 2 to 3
  3. Notable Eligibility criteria expanded, about 15 wordsv11
  4. Notable Enrollment target: 300 to 175v10
  5. Notable Eligibility criteria expanded, about 14 words
    • Study description expanded, about 2 words
    v9
Show 5 earlier versionsHide 5 earlier versions
  1. Notable Eligibility criteria shortened, about 143 words
    • Primary completion date: Dec 2026 to Jun 30, 2026
    • Study completion date: Dec 2026 to Dec 31, 2026
    • Study description expanded, about 283 words
    v7
  2. Notable Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    • Start date changed from estimate of Dec 31, 2021 to Jan 1, 2022
    v5
  3. Notable Start date: Aug 2021 to Dec 31, 2021v4
  4. Notable Start date: Apr 2021 to Aug 2021v3
  5. Notable Start date: Jan 2021 to Apr 2021v2
  1. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Pathologic Complete Response (pCR) and Organ Preservation Rate
Timeframe: at end of 6-month intervention
Patient-Reported AEs (PRO-CTCAEs)
Timeframe: at end of 6-month intervention

Secondary (4)

Clinical Response
Tumor Response
Provider-Reported AEs (Treatment Related Toxicities)
Health-Related Quality of Life

Arms and interventions

Time-Restricted Eating (TRE)Experimental

8-hour daily eating period. Participants eating window must start within 2 hours of waking up and no later than 9 am.

ControlActive comparator

More than equal to a 12-hour daily eating period

Behavioral: Time-Restricted Eating (TRE), Control

Sites

2 sites in 1 country